| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1076651A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 02/21/2001 | EP1076644A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | CN1284941A Novel antiarrhythmic compounds |
| 02/20/2001 | US6191277 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases |
| 02/20/2001 | US6191171 Para-aminomethylaryl carboxamide derivatives |
| 02/20/2001 | US6191170 Benzenesulfonamides and benzamides as therapeutic agents |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 02/14/2001 | EP0777511B1 Fluorochemical foam stabilizers and film formers |
| 02/14/2001 | CN1284072A Prodrugs of aspartyl protease inhibitors |
| 02/14/2001 | CN1284071A Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/13/2001 | US6187924 Inhibitors of matrix metalloproteinases and/or tumor necrosis factor-alpha-mediated diseases |
| 02/13/2001 | US6187809 Beta-3 adrenaline receptor agonist drugs for the treatment of diabetes, obesity, and hyperlipemia; 2-(n-(2-(dibenzofuran-3-yloxy)ethyl)amino)-1-phenylethanol, for example |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2001009087A1 Substituted arylhydrazone carboxylic acid derivatives and their use as herbicides |
| 02/08/2001 | WO2001008674A1 Sulfonamide derivatives and remedies for allodynia |
| 02/08/2001 | WO2001008672A2 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | DE19937494A1 New carboxylic acid amides are Factor Xa and serine protease inhibitors, useful for the treatment and prevention of thrombotic disorders, tumors and fibrin-dependent inflammation |
| 02/08/2001 | DE19936360A1 Substituierte Arylhydrazoncarbonsäurederivate Substituted Arylhydrazoncarbonsäurederivate |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073623A1 Substituted amino acids as erythropoietin mimetics |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1061653C Benzofuran compounds, process for their preparation and pharmaceutical compositions thereof |
| 02/01/2001 | WO2001007404A1 Crystalline modification iii of n-(4-(5-dimethylamino-naphthaline-1-sulfonylamino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamide |
| 02/01/2001 | WO2001007403A1 Naphthyl-substituted sulfonamides |
| 02/01/2001 | WO2001007402A1 Antiviral agents |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 02/01/2001 | CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/31/2001 | EP1071648A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 01/31/2001 | EP1071426A2 Novel compounds and their use as positive ampa receptor modulators |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/30/2001 | US6180796 Sulfonamide derivatives |
| 01/30/2001 | US6180675 IL-8 receptor antagonists |
| 01/30/2001 | US6180665 Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
| 01/25/2001 | WO2001005393A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005389A2 N-sulfonylaminiacid derivatives as inhibitors of metalloprteinase |
| 01/25/2001 | WO2001005354A2 Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | DE19934394A1 New N-phenylnaphthalenesulfonamide derivatives useful for treatment and prevention of viral infection, especially cytomegalovirus |
| 01/25/2001 | DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections |
| 01/25/2001 | DE19934295A1 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections |
| 01/25/2001 | CA2379657A1 Phosphate transport inhibitors |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2378381A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070055A1 Substituted phenyl pyridazinones |
| 01/24/2001 | EP1070048A1 Calcilytic compounds |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |
| 01/24/2001 | CN1281451A Benzamine derivatives |
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/24/2001 | CN1061045C Process for preparation of new cephalosporins containing in position 7 substituted benzyloxyimino radical |
| 01/23/2001 | US6177573 Process to prepare taxol |
| 01/23/2001 | US6177466 Matrix metalloproteinase inhibitors |
| 01/18/2001 | WO2001004100A1 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate |
| 01/18/2001 | WO2001004092A1 Process for the preparation of tricyclic amino alcohol derivatives |
| 01/18/2001 | WO2001004087A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/18/2001 | CA2377760A1 Process for the preparation of tricyclic amino alcohol derivatives |
| 01/17/2001 | EP1069110A1 Sulfonamide derivatives |
| 01/17/2001 | EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1067894A2 Protease inhibitors |
| 01/17/2001 | EP0725059B1 2,3-diaminopropionic acid derivative |
| 01/17/2001 | CN1060767C Substituted benzene sulfonyl usea and benzene sulfonyl thiourea and mfg, method and use as raw material for medicine and medicine containing them |
| 01/16/2001 | US6174923 Administering ethynyl alanine amino diol compound for treating hypertension |
| 01/16/2001 | US6174922 Sulphonamide derivatives |
| 01/16/2001 | US6174921 Antitumor compositions and methods of treatment |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt |
| 01/11/2001 | WO2001002350A2 Novel amino sulfonamides and amido sulfonamides as antiviral agents |
| 01/10/2001 | EP1066276A1 Process for the synthesis of hiv protease inhibitors |
| 01/10/2001 | EP1066264A2 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods |
| 01/10/2001 | EP1066246A1 Novel cationic couplers and their use for oxidation dyeing |